Viatris Inc
NASDAQ:VTRS
Viatris Inc
PP&E Gross
Viatris Inc
PP&E Gross Peer Comparison
Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Viatris Inc
NASDAQ:VTRS
|
PP&E Gross
$3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
Johnson & Johnson
NYSE:JNJ
|
PP&E Gross
$19.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
PP&E Gross
$8.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
|
Pfizer Inc
NYSE:PFE
|
PP&E Gross
$18.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
PP&E Gross
$23B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
|
Eli Lilly and Co
NYSE:LLY
|
PP&E Gross
$13.6B
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
6%
|
See Also
What is Viatris Inc's PP&E Gross?
PP&E Gross
3B
USD
Based on the financial report for Mar 31, 2024, Viatris Inc's PP&E Gross amounts to 3B USD.
What is Viatris Inc's PP&E Gross growth rate?
PP&E Gross CAGR 10Y
6%
Over the last year, the PP&E Gross growth was -10%. The average annual PP&E Gross growth rates for Viatris Inc have been -6% over the past three years , 4% over the past five years , and 6% over the past ten years .